Easterly Investment Partners LLC Purchases New Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Easterly Investment Partners LLC bought a new stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 68,833 shares of the company's stock, valued at approximately $986,000. Easterly Investment Partners LLC owned about 0.15% of Avanos Medical as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of AVNS. Quantbot Technologies LP bought a new position in Avanos Medical in the 4th quarter valued at $64,000. State of Wyoming increased its stake in shares of Avanos Medical by 132.0% in the 4th quarter. State of Wyoming now owns 5,137 shares of the company's stock valued at $82,000 after buying an additional 2,923 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Avanos Medical by 493.3% in the 4th quarter. Tower Research Capital LLC TRC now owns 8,075 shares of the company's stock valued at $129,000 after buying an additional 6,714 shares during the period. Heritage Family Offices LLP acquired a new stake in shares of Avanos Medical in the 1st quarter valued at $146,000. Finally, EP Wealth Advisors LLC increased its stake in shares of Avanos Medical by 14.6% in the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock valued at $161,000 after buying an additional 1,289 shares during the period. Institutional investors and hedge funds own 95.17% of the company's stock.

Avanos Medical Trading Down 3.4%

Shares of Avanos Medical stock traded down $0.39 during trading on Friday, reaching $11.25. 450,766 shares of the company were exchanged, compared to its average volume of 392,004. The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 0.12. Avanos Medical, Inc. has a twelve month low of $11.21 and a twelve month high of $25.36. The business has a 50-day moving average price of $12.32 and a 200-day moving average price of $13.87. The firm has a market capitalization of $520.25 million, a price-to-earnings ratio of -1.34 and a beta of 1.12.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. Avanos Medical had a positive return on equity of 6.26% and a negative net margin of 55.80%. The firm had revenue of $167.50 million during the quarter, compared to analysts' expectations of $161.75 million. During the same period in the previous year, the firm earned $0.22 earnings per share. The company's revenue was up .8% on a year-over-year basis. Sell-side analysts anticipate that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.